The company offloaded more than 8.33 million shares at $14 apiece. This pricing sits at the bottom of the projected $14 to $16 range established prior to the debut. The shares are scheduled to begin active trading on Friday, marking a significant milestone for the firm as it transitions into the public markets.
TRex Bio Prices IPO at $14 per Share
Trading at the low end of expectations, South San Francisco-based TRex Bio finalized its initial public offering late Thursday. The clinical-stage biotechnology firm secured approximately $116.7 million in capital, signaling a cautious market reception as shares prepare to hit the Nasdaq Global Select Market under the ticker TRXB.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!